Asian expansion of FlexiOss® 2024

This is a big step towards the Asian expansion of FlexiOss®!

Our bone substitute composite dedicated to orthopaedics has been officially approved for marketing in Singapore. The presence in this market is a milestone for Medical Inventi S.A. in its chosen strategy of foreign expansion and product commercialisation.

Since 2023, we have been working with a local distributor in the area, so the process of entering this market is fully planned. For now, FlexiOss® will only be used in Singaporean medical facilities for patients with orthopaedic problems. However, we do not rule out the release of our other products in the territory, which have applications in dentistry – FlexiOss®Dent – and in veterinary medicine – FlexiOss®Vet.

– Singapore, although the smallest member of the Association of South East Asian Nations, plays an extremely important role in this organisation. Its influence extends far beyond its small geographical size, so in line with our global commercialisation strategy for FlexiOss®, we are working hard to expand the availability of our products in the Eastern Countries. In addition, world-class healthcare as it is in Singapore will allow orthopaedists there to become convinced of the attractiveness of FlexiOss® straight from Poland,’ points out Anna Kasprzak-Czelej, Vice President of the Management Board of Medical Inventi.